These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 11897288)
1. Fatal allergic vasculitis associated with celecoxib. Schneider F; Meziani F; Chartier C; Alt M; Jaeger A Lancet; 2002 Mar; 359(9309):852-3. PubMed ID: 11897288 [TBL] [Abstract][Full Text] [Related]
2. Allergic vasculitis associated with celecoxib. Jordan KM; Edwards CJ; Arden NK Rheumatology (Oxford); 2002 Dec; 41(12):1453-5. PubMed ID: 12468830 [No Abstract] [Full Text] [Related]
3. [Allergic vasculitis following ingestion of celecoxib?]. Gscheidel D; Daspet MK; Le Coz CJ; Lipsker D Hautarzt; 2002 Jul; 53(7):488-91. PubMed ID: 12219273 [TBL] [Abstract][Full Text] [Related]
4. Cutaneous vasculitis related to celecoxib. Skowron F; Bérard F; Bernard N; Balme B; Perrot H Dermatology; 2002; 204(4):305. PubMed ID: 12077531 [No Abstract] [Full Text] [Related]
5. [Case report: reversible acute renal failure following therapy with both ketorolac (non-selective non-steroidal anti-inflammatory drug NSAID) and celecoxib (COX-2 selective) in the same patient]. Galli G; Panzetta G G Ital Nefrol; 2002; 19(2):199-203. PubMed ID: 12195419 [TBL] [Abstract][Full Text] [Related]
6. Cutaneous vasculitis induced by cyclo-oxygenase-2 selective inhibitors. Drago F; Brusati C; Desirello G; Cacciapuoti M; Rebora A J Am Acad Dermatol; 2004 Dec; 51(6):1029-30. PubMed ID: 15583611 [No Abstract] [Full Text] [Related]
7. Celecoxib, a highly selective COX-2 inhibitor, is safe in aspirin-induced asthma patients. Martín-García C; Hinojosa M; Berges P; Camacho E; García-Rodriguez R; Alfaya T J Investig Allergol Clin Immunol; 2003; 13(1):20-5. PubMed ID: 12861847 [TBL] [Abstract][Full Text] [Related]
12. Drug Points: Cholestatic hepatitis in association with celecoxib. O'Beirne JP; Cairns SR BMJ; 2001 Jul; 323(7303):23. PubMed ID: 11440939 [No Abstract] [Full Text] [Related]
13. Risk of gastrointestinal effects with COX-2 inhibitors and NSAIDs: what does evidence from randomised trials show about celecoxib? Underhill JL BMJ; 2005 Dec; 331(7530):1474-5. PubMed ID: 16356996 [No Abstract] [Full Text] [Related]
14. [Hyperkalemia and celecoxib]. Rego MJ; Fonseré N; Martí S; Rey-Joly C Med Clin (Barc); 2002 Jun; 119(1):36-7. PubMed ID: 12062005 [No Abstract] [Full Text] [Related]
15. Anaphylaxis to celecoxib. Grob M; Pichler WJ; Wüthrich B Allergy; 2002 Mar; 57(3):264-5. PubMed ID: 11906348 [No Abstract] [Full Text] [Related]
16. Celecoxib in patients with asthma and aspirin intolerance. The Celecoxib in Aspirin-Intolerant Asthma Study Group. Dahlén B; Szczeklik A; Murray JJ; N Engl J Med; 2001 Jan; 344(2):142. PubMed ID: 11188419 [No Abstract] [Full Text] [Related]
17. Risk of gastrointestinal effects with COX-2 inhibitors and NSAIDs: study conclusions do not reflect findings for celecoxib. Feczko J BMJ; 2005 Dec; 331(7530):1473-4. PubMed ID: 16356991 [No Abstract] [Full Text] [Related]
18. Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis. Goldstein JL; Correa P; Zhao WW; Burr AM; Hubbard RC; Verburg KM; Geis GS Am J Gastroenterol; 2001 Apr; 96(4):1019-27. PubMed ID: 11316141 [TBL] [Abstract][Full Text] [Related]